Skip to main content
OpenTrials

Clinical trial condition

Amyloidosis

Explore clinical trials studying Amyloidosis. Study availability and eligibility vary by location and protocol.

187 public trials 49 recruiting studies
Refine in advanced search Browse all conditions

Amyloidosis trial results

Completed

Phase 1/2 Study of ZN-d5 for the Treatment of Relapsed or Refractory Light Chain (AL) Amyloidosis

NCT05199337

Conditions
AL Amyloidosis, Amyloidosis, Immune System Diseases, +10 more
Locations
  • University of Southern California Los Angeles, California, United States
  • Colorado Blood Cancer Institute Denver, Colorado, United States
  • Tulane University New Orleans, Louisiana, United States
  • Washington University St Louis, Missouri, United States
View all 21 locations
View Trial Details
Completed

Efficacy and Safety of AG10 in Subjects With Transthyretin Amyloid Cardiomyopathy

NCT03860935

Conditions
Alzheimer Disease, Amyloid Cardiomyopathy, Amyloid Neuropathies, +25 more
Locations
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • Pacific Heart Institute Santa Monica, California, United States
  • University of Colorado Hospital - Anschutz Medical Campus Aurora, Colorado, United States
  • Yale School of Medicine New Haven, Connecticut, United States
View all 104 locations
View Trial Details
Completed

APOLLO: The Study of an Investigational Drug, Patisiran (ALN-TTR02), for the Treatment of Transthyretin (TTR)-Mediated Amyloidosis

NCT01960348

Conditions
Amyloid Neuropathies, Amyloid Neuropathies, Familial, Amyloidosis, +16 more
Locations
  • Clinical Trial Site La Mesa, California, United States
  • Clinical Trial Site Orange, California, United States
  • Clinical Trial Site Denver, Colorado, United States
  • Clinical Trial Site Chicago, Illinois, United States
View all 52 locations
View Trial Details
Completed

The Study of an Investigational Drug, Patisiran (ALN-TTR02), for the Treatment of Transthyretin (TTR)-Mediated Amyloidosis in Participants Who Have Already Been Treated With ALN-TTR02 (Patisiran)

NCT02510261

Conditions
Amyloid Neuropathies, Amyloid Neuropathies, Familial, Amyloidosis, +12 more
Locations
  • Clinical Trial Site La Mesa, California, United States
  • Clinical Trial Site Aurora, Colorado, United States
  • Clinical Trial Site Jacksonville, Florida, United States
  • Clinical Trial Site Chicago, Illinois, United States
View all 56 locations
View Trial Details
Completed

Extension Study Assessing Long Term Safety and Efficacy of IONIS-TTR Rx in Familial Amyloid Polyneuropathy (FAP)

NCT02175004

Conditions
Amyloid Neuropathies, Amyloid Neuropathies, Familial, Amyloidosis, +16 more
Locations
  • University of California, Irvine Orange, California, United States
  • Indiana University School of Medicine Indianapolis, Indiana, United States
  • Johns Hopkins University Bayview Medical Center Baltimore, Maryland, United States
  • Boston University School of Medicine - Amyloid Treatment & Research Program Boston, Massachusetts, United States
View all 22 locations
View Trial Details

Related conditions